好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Comparison of Zonisamide and Carbamazepine Monotherapy in Adults with Newly Diagnosed Partial Epilepsy: Results of a Phase III, Randomized, Double-Blind, Non-Inferiority Trial
Epilepsy
(-)
005
Authors/Disclosures
Michel Baulac, MD No disclosure on file
Martin Brodie Martin Brodie has nothing to disclose.
No disclosure on file
Luigi Giorgi, MD No disclosure on file
Richard J. Barohn, MD, FAAN (University of Missouri) Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.